Analysis of RGS protein palmitoylation.

Methods Mol Biol

Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA.

Published: February 2004

Palmitoylation refers to the covalent attachment of a 16-carbon fatty acid to cysteine residues of proteins. This modification occurs on many intracellular signaling proteins including regulators of G protein signaling proteins (RGS). Palmitoylation mediates the interaction of proteins with membranes and other proteins and can control the biological activity of a protein. Palmitate attachment occurs through a labile thioester bond and is readily reversible in cells, thus providing a particularly important means for protein regulation. This chapter presents protocols for investigating RGS protein palmitoylation in mammalian cells. The RGS protein of interest is heterologously expressed in HEK293 cells, and cells are metabolically labeled with [3H]palmitate. The RGS protein is isolated from fractionated cells by immunoprecipitation and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography to determine if [3H] has been incorporated. To confirm that the radiolabeled fatty acid is linked to the protein through a thioester bond, labeled proteins are treated with neutral hydroxylamine. Oxyester-linked palmitate, which is occasionally found on serine and threonine residues, is insensitive to this treatment, whereas thioesters are sensitive. To verify that incorporated radiolabel is palmitate, the protein is treated with base, which also cleaves thioester bonds. The resulting lipids are extracted from the sample, then analyzed by chromatography.

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-430-1:195DOI Listing

Publication Analysis

Top Keywords

rgs protein
16
protein
9
protein palmitoylation
8
fatty acid
8
signaling proteins
8
thioester bond
8
proteins
6
cells
5
analysis rgs
4
palmitoylation
4

Similar Publications

Background: Regulator of G protein signaling (RGS) proteins participate in tumor formation and metastasis by acting on the α-subunit of heterotrimeric G proteins. The specific effect of RGS, particularly , on the progression of gastric cancer (GC) is not yet clear.

Aim: To explore the role and underlying mechanisms of action of in GC development.

View Article and Find Full Text PDF

The vasodilator hydralazine (HYZ) has been used clinically for ~ 70 years and remains on the World Health Organization's List of Essential Medicines as a therapy for preeclampsia. Despite its longstanding use and the concomitant progress toward a general understanding of vasodilation, the target and mechanism of HYZ have remained unknown. We show that HYZ selectively targets 2-aminoethanethiol dioxygenase (ADO) by chelating its metal cofactor and alkylating one of its ligands.

View Article and Find Full Text PDF

The sodium phosphate cotransporter-2A (NPT2A) mediates basal and parathyroid hormone (PTH)- and fibroblast growth factor-23 (FGF23)-regulated phosphate transport in proximal tubule cells of the kidney. Both basal and hormone-sensitive transport require sodium hydrogen exchanger regulatory factor-1 (NHERF1), a scaffold protein with tandem PDZ domains, PDZ1 and PDZ2. NPT2A binds to PDZ1.

View Article and Find Full Text PDF

Regulators of G protein signaling (RGS) proteins finetune signaling via heterotrimeric G proteins to maintain physiologic homeostasis in various organ systems of the human body including the brain, kidney, heart, and the vasculature. Impaired regulation of G protein signaling by RGS proteins is implicated in the pathogenesis of several human diseases including various forms of cardiomyopathy such as hypertrophic cardiomyopathy and dilated cardiomyopathy (DCM). Both genetic and non-genetic changes that impinge on G protein signaling in cardiomyocytes are implicated in the etiology of DCM, and there is accumulating evidence that such genetic and non-genetic changes affecting G protein signaling in cell types other than cardiomyocytes could serve as a DCM trigger in humans.

View Article and Find Full Text PDF
Article Synopsis
  • MitoNEET, an iron-sulphur protein in the mitochondrial outer membrane, is linked to the drug pioglitazone but its exact molecular function remains unclear.
  • Researchers identified a specific site for nitric oxide (NO) access to the mitoNEET's [2Fe-2S] cluster and found that both oxygen and pioglitazone can block this access.
  • This discovery suggests a role for mitoNEET in mitochondrial signal transduction related to hypoxia, revealing new insights into how [Fe-S] clusters may function in signaling processes in eukaryotic cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!